The science is moving. Funding it now changes when we get there.
For the first time in history, the targets exist, the tools exist,
and the trials are running. What's needed is sustained funding.
Research that was once impossible is happening today.
For decades, Parkinson's was considered too complex, too many mechanisms, too few biomarkers, too little funding. That has changed. The discovery of alpha-synuclein's role, advances in dopamine pathway research, and the development of the Parkinson's Progression Markers Initiative (PPMI) have given researchers new targets, new tools, and real momentum.
What's needed now is sustained funding to carry that momentum through clinical trials, through validation, and into treatment. That is where philanthropy matters. That is where your gift matters.
The Michael J. Fox Foundation has identified the most promising research pathways and funds them with discipline. We raise funds as a Team Fox group, MJFF's grassroots fundraising program. Funds raised benefit The Michael J. Fox Foundation for Parkinson's Research.
Direct. Transparent. No detours.
The Michael J. Fox Foundation
for Parkinson's Research
MJFF is the world's largest private funder of Parkinson's research. We raise funds as a Team Fox group, MJFF's grassroots fundraising program. Since 2006, Team Fox has raised over $185 million for the Foundation. We chose MJFF because of their rigor, their transparency, and their singular focus on curing Parkinson's disease.